Skip to main content

Doctor Strange in the Multiverse of Madness loses director Scott Derrickson

Doctor Strange in the Multiverse of Madness needs a new director after Scott Derrickson decided the project is no longer for him.

Derrickson confirmed his departure in a tweet posted on Thursday evening, saying: “Marvel and I have mutually agreed to part ways on Doctor Strange: In the Multiverse of Madness due to creative differences.”

He added that he was thankful for the collaboration and said he would stay on as an executive producer.

Derrickson declined to offer any details regarding his particular grievances, but he may shed some light on his decision once the dust has settled.

“Creative differences” can mean a whole range of things, from disputes over the script or style of the movie, to friction over the cast or size of the budget. As noted by The Hollywood Reporter, the 53-year-old writer, director, and producer tweeted somewhat cryptically just last month that “studio release dates are the enemy of art,” a comment that may have indicated he wanted more time to work on the production.

Scott Derrickson. Axelle/Bauer-Griffin/Getty Images

It’s also worth noting that while he wrote and directed the 2016 Doctor Strange movie, he had no hand in the script for the sequel. In addition, Derrickson promised at Comic-Con 2019 that Doctor Strange in the Multiverse of Madness would be “the first scary” Marvel movie, a desire that Marvel Studios may have pushed back on.

The movie was expected to start filming in May 2020, ahead of a release currently set for May 2021. With the news of Derrickson’s departure only just breaking, it’s too early to say what impact it will have on the movie’s scheduling, but it’ll need to find a director pretty soon if shooting is to start in the spring.

This isn’t the first time a director has turned their back on a movie and it won’t be the last. Danny Boyle, for example, caused a stir in 2018 when he suddenly departed the latest James Bond project, also citing creating differences.

Editors' Recommendations

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
From mighty to meh: the MCU is dying and needs to change fast
The Avengers attend Tony Stark's funeral in Avengers: Endgame.

The summer of 2019 delivered what remains arguably the cinematic event of the millennial generation. Avengers: Endgame was the culmination of 11 years of world-building and 22 films, and audiences ate it up like a big, fat turkey on Thanksgiving Day. The Marvel Cinematic Universe pulled a feat no other franchise had, before or since, delivering spectacular thrills and unforgettable moments while tying all its loose ends in a messy but still attractive bow.

It wouldn't be an overstatement to call Endgame the event of a lifetime, even if the declaration would make some film purists cringe. The film was the perfect representation of the MCU's brand, a collection of jokes, characters, and stories so ambitious and, dare we say it, daring that they changed the way we consume cinema. The film, and the entire MCU concept, was an undertaking of Herculean proportions, and it was successfully pulled off, dazzling audiences and leaving them in shock and awe at the overindulgence they witnessed on the big screen.

Read more
Hollywood is abandoning movie theaters at the wrong time
Tom Cruise flys a plane in Top Gun: Maverick.

After a rough two years in which the COVID pandemic and the rise of streaming services contributed to a record decline in audiences going to movie theaters, Hollywood is seemingly coming back. Franchise tentpoles like Jurassic Park Dominion and Minions: The Rise of Gru posted healthy opening weekends, while Marvel recovered from the pandemic low of Eternals and is once again posting worldwide grosses for Doctor Strange in the Multiverse of Madness and Thor: Love and Thunder that flirt with $1 billion (or soon will be). And above all else, Top Gun: Maverick continues to make money week after week, becoming Paramount's biggest hit since Titanic.

All that progress, however, is increasingly likely to stop in August, when a dearth of product will threaten the recovery of the theatrical experience -- and the sustainability of Hollywood's traditional business model. The already dire situation got even worse, with Warner Bros. recently pushing back the Stephen King adaptation Salem's Lot and MGM opting to release the Sylvester Stallone-led genre film Samaritan on Prime Video. While both films are not guaranteed blockbusters, their absence is all the more pronounced with what's left on the theatrical calendar for August, September, and even October: cheap horror films, indie movies with little hope of crossover appeal, and re-releases of past hits like Avatar, Jaws, and E.T.

Read more
How VFX gave Doctor Strange’s Gargantos a magic makeover
Doctor Strange stands on a street facing the monstrous, tentacled creature Gargantos in a scene from Doctor Strange in the Multiverse of Madness.

Superhero sorcerer Stephen Strange sent Marvel Studios back to the top of the box office with Doctor Strange in the Multiverse of Madness, which had Benedict Cumberbatch's titular hero explore the myriad dimensions of the Marvel Cinematic Universe.

Not only did the film introduce a long list of new characters, but it also brought filmmaker Sam Raimi back to Marvel after the Evil Dead director helmed the original, pre-MCU trilogy of Spider-Man films. To no one's surprise, Raimi delivered one of the franchise's darkest, most horror-fueled films to date, complete with terrifying zombies, gruesome deaths, and Gargantos -- a massive, tentacled creature from a nightmarish dimension that tore apart Manhattan in the movie's wild, opening scene.

Read more